PIN1 and breast carcinoma: Thus, based on our findings, we determined whether pharmacological inhibition of PIN1 is sufficient to disrupt the FA pathway via FAAP20 destabilization in breast cancer, where high levels of PIN1 have been correlated with aggressiveness and chemoresistance [40].